Back to top
more

USANA Health Sciences (USNA)

(Delayed Data from NYSE)

$42.98 USD

42.98
69,524

-0.49 (-1.13%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $42.98 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (94 out of 251)

Industry: Medical - Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks.com featured highlights include: MED, SYX, USNA, HUM and XPEL

by Zacks Equity Research

Zacks.com featured highlights include: MED, SYX, USNA, HUM and XPEL

Sanghamitra Saha headshot

Play DuPont Technique to Bet on 5 Top-Ranked Stocks

by Sanghamitra Saha

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

Has USANA Health Sciences (USNA) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Is (USNA) Outperforming Other Medical Stocks This Year?

Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System

by Zacks Equity Research

Zacks.com featured highlights include: Medifast, USANA Health, UFP Industries, AllianceBernstein and Landstar System

Sanghamitra Saha headshot

6 Must-Buy Quality Stocks Screened on DuPont Analysis

by Sanghamitra Saha

Bet on six top-ranked stocks with higher ROE derived the DuPont way.

    Has USANA Health Sciences (USNA) Outpaced Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (USNA) Outperforming Other Medical Stocks This Year?

    USANA Health Sciences (USNA) Tops Q2 Earnings Estimates

    by Zacks Equity Research

    USANA Health (USNA) delivered earnings and revenue surprises of 10.92% and -3.29%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

    Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein

    by Zacks Equity Research

    Zacks.com featured highlights include: Medifast, USANA Health Sciences, UFP Industries, EMCOR and AllianceBernstein

    Zoetis (ZTS) Hits 52-Week High, Can the Run Continue?

    by Zacks Equity Research

    Zoetis (ZTS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    Top Ranked Momentum Stocks to Buy for July 21st

    by Zacks Equity Research

    Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, July 21st

    Sanghamitra Saha headshot

    Explore 5 Top-Ranked Stocks Through DuPont Analysis

    by Sanghamitra Saha

    Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

    USANA (USNA) to Report Q2 Earnings: What's in the Cards?

    by Zacks Equity Research

    USANA (USNA) will release second-quarter 2020 results, which are likely to reflect impacts of the COVID-19 pandemic.

    Will USANA Health Sciences Continue to Surge Higher?

    by Zacks Equity Research

    As of late, it has definitely been a great time to be an investor of USANA Health Sciences

    Tirthankar Chakraborty headshot

    New Strong Buy Stocks For July 17th

    by Tirthankar Chakraborty

    Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

    Has USANA Health Sciences (USNA) Outpaced Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (USNA) Outperforming Other Medical Stocks This Year?

    USANA Health Sciences (USNA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    by Zacks Equity Research

    USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    AbbVie (ABBV) Hits Fresh High: Is There Still Room to Run?

    by Zacks Equity Research

    AbbVie (ABBV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    Sanghamitra Saha headshot

    5 DuPont-Tested Winning Stocks

    by Sanghamitra Saha

    Use the DuPont technique to pick solid profit-generating stocks.

    Pacira (PCRX) Hits 52-Week High, Can the Run Continue?

    by Zacks Equity Research

    Pacira (PCRX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

    Zacks.com featured highlights include: eXp World, USANA Health Sciences, Fortinet and Logitech International

    by Zacks Equity Research

    Zacks.com featured highlights include: eXp World, USANA Health Sciences, Fortinet and Logitech International

    Power Your Portfolio With These 4 Top-Ranked Liquid Gems

    by Zacks Equity Research

    Here are four excellent liquid stocks, including Fortinet (FTNT), that can contribute to making an outstanding portfolio for yield-seeking investors.

    Tirthankar Chakraborty headshot

    New Strong Buy Stocks for June 26th

    by Tirthankar Chakraborty

    Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

    Tirthankar Chakraborty headshot

    New Strong Buy Stocks for June 24th

    by Tirthankar Chakraborty

    Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

    Sanghamitra Saha headshot

    DuPont: A Less-Traversed Path to Pick 5 Winning Stocks

    by Sanghamitra Saha

    Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

      Tirthankar Chakraborty headshot

      New Strong Buy Stocks For June 17th

      by Tirthankar Chakraborty

      Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today: